iScribe Health

iScribe Health is an enterprise-priced AI medical scribe in the healthcare documentation category that uses ambient speech-to-text and generative AI to automate clinical note creation for physicians. Pricing is not publicly listed and requires a custom sales quote, though comparable AI scribe platforms in this market typically range from $99 to $399 per provider per month based on publicly available pricing from competitors such as Suki AI, DeepScribe, and Nabla.

The platform works by passively listening to patient-provider conversations using ambient speech-to-text technology, then applying generative AI to produce structured clinical notes—including SOAP notes, HPI, and assessment and plan sections—returned directly to the provider's EHR. The vendor states notes are delivered in 30 seconds or less, though this claim has not been independently verified.

iScribe Health differentiates itself through provider-level AI customization, allowing each clinician to tailor note structure, terminology, and documentation style to their individual preferences and specialty requirements. This flexibility makes it particularly suited for multi-specialty group practices where documentation standards vary across departments.

Beyond clinical note generation, the platform positions itself as a practice optimization tool that accelerates billing, scheduling, and prior authorizations—all workflows contingent on completed documentation. Florida Orthopaedic Institute, a case study cited by the vendor, reported $120,000 in annual savings across 92 users (approximately $1,300 per user per year) after adopting the platform. This figure is vendor-reported and has not been independently audited.

The platform supports both desktop and mobile (iOS and Android) access for in-person and telehealth encounters, integrates with major EHR systems, and operates on HIPAA-compliant infrastructure with encrypted data transmission and storage. The vendor advertises same-day deployment capability, though actual deployment timelines may vary depending on EHR integration complexity and practice size. A sales-guided evaluation period is available, though interested practices must contact the sales team to initiate access rather than signing up through a self-service portal.

Key limitations include the lack of publicly available pricing, no published list of specific EHR integrations, a primary focus on outpatient and ambulatory care in the United States, and the absence of independent third-party accuracy benchmarks or peer-reviewed validation studies. Prospective buyers should confirm EHR compatibility and request references during the sales evaluation process.